Next on Kentucky Health. >> Kentucky Health is funded in part by a grant from the Foundation for a Healthy Kentucky. >> I ...
Key Takeaways The Ohio State University Wexner Medical Center is the first in the Midwest to treat a patient in a trial ...
Medtronic continues to strengthen its position in cardiac ablation, building on a legacy of innovation in electrophysiology ...
Medtronic plc announced positive real-world registry results for the Affera Mapping and Ablation System with the Sphere-9? Catheter and the PulseSelect Pulsed Field Ablation (PFA) System. The global ...
This is an introduction to the Amazon bestseller, "Learning ECG from Now On: The World's Easiest Textbook." This book aims to ...
A 48-year-old woman with no history of hypertension, diabetes, coagulopathy or familial connective-tissue disorder arrived at ...
A 13-year Turkish study of intensive care patients with external ventricular drains found that nearly two-thirds of ...
Medtronic's Sphere-9 catheter and Affera mapping and ablation system has secured a CE mark in Europe for ventricular arrhythmia treatment. The integrated mapping and ablation catheter obtained its ...
The immune system consists of 1.8 trillion cells distributed across every tissue of the human body. And yet, size alone cannot capture how complex the system really is. “The immune system interfaces ...
LAGUNA HILLS, Calif., May 21, 2026--(BUSINESS WIRE)--Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of ...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results